Article
ALKBH5 enhances efficiency of anti-PD-1/PD-L1 therapy by reducing Lnc-XIST/miRNA- 124-3p mediated FGL1 expression in bladder cancer
2022-10-11
Abstract excerpt
<h4>Background: </h4> Fibrinogen-like 1 (FGL1), the promising inhibitory immune checkpoint, has been proved to promote immune escape and abrogate the efficacy of immunotherapy in malignancy. However, knowledge on its dynamic expression and regulatory mechanism in course of cancer immunotherapy is limited in bladder cancer (BCa). The vital roles of N6‑methyladenosine (m6A) RNA methylation have been identified in mu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- da260759-e3e1-515d-9b54-d1ea76dd2168
- DOI
- 10.21203/rs.3.rs-2137267/v1
